Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Merck & Co. and MD Anderson to evaluate pembrolizumab combination therapies for solid tumors

Aug. 14, 2015

ImmunoCellular Therapeutics and FDA reach agreement on SPA for ICT-107

Aug. 14, 2015

Novartis studies MCS-110 in phase II trial for triple negative breast cancer

Aug. 13, 2015

Janssen Biotech enters license agreement for Alligator's ADC-1013

Aug. 12, 2015

Immune Design and Merck & Co. collaborate to study immunotherapies with Keytruda

Aug. 12, 2015

Phase I study investigates ADCT-301 for relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma

Aug. 12, 2015

Phase I study investigates DNA vaccine pTVG-AR for metastatic prostate cancer

Aug. 11, 2015

Inovio and MedImmune establish cancer vaccine collaboration

Aug. 11, 2015

MabVax and Rockefeller University enter into research collaboration agreement

Aug. 11, 2015

The FDA grants orphan drug designation to daratumumab for follicular lymphoma

Aug. 10, 2015

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...